Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ RIPAb+™ IGF2 mRNA-Binding Protein 3 RIP Validated Antibody and Primer Set

Catalog No. 03198MI Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
10 Assays/Set (approx. 5μg of antibody per RIP)
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
03-198MI 10 Assays/Set (approx. 5μg of antibody per RIP)
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 03-198MI Supplier MilliporeSigma™ Supplier No. 03198
Only null left
Add to Cart
Add to Cart

This RIPAb+ IGF2 mRNA-binding protein 3 -RIP Validated Antibody and Primer Set conveniently includes the antibody and the specific control PCR primers.

Includes negative control normal rabbit IgG antibody and control primers specific for the cDNA of human IGF2.
TRUSTED_SUSTAINABILITY

Specifications

Applications Immunoprecipitation, Western Blot
Classification Polyclonal
Gene Accession No. NP_006538
Gene Symbols IGF2BP3, IMP-3, IMP3, KOC1, VICKZ3, hKOC
Host Species Rabbit
Immunogen KLH-conjugated linear peptide corresponding to human IGF2 mRNA-binding protein 3 at and around the C-terminus.
Purification Method Affinity Purfied
Quantity 10 Assays/Set (approx. 5μg of antibody per RIP)
Target Species Canine, Chimpanzee, Equine, Human, Mouse
Content And Storage -20°C for 12 months.
Product Type RIPAb+ IGF2 mRNA-Binding Protein 3 RIP Validated Antibody and Primer Set
Form Purified
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.